David Melnychuk

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

Medicine, Oncology, Pharmacology +12

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 424 citations

Medicine, Oncology, Surgery +17

Phase I clinical trial of i.v. ascorbic acid in advanced malignancy

L. John Hoffer, Mark Levine, Sarit Assouline et al. · Annals of Oncology · 2008 · 372 citations · Full text

Medicine, Oncology, Pharmacology +5

Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

Denis Talbot, Vladimir Moiseyenko, Simon Van Belle et al. · British Journal of Cancer · 2002 · 181 citations · Full text

Medicine, Oncology, Pharmacology +15

High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial

L. John Hoffer, Line Robitaille, Robert Zakarian et al. · PLoS ONE · 2015 · 118 citations · Full text

Medicine, Oncology, Pharmacology +15